Tonix Launches Phase 2 HORIZON Trial of TNX-102 SL for Major Depressive Disorder - The Clinical Trial Vanguard

Submitted by Anonymous (not verified) on Wed, 07/01/2026 - 06:53

Tonix Launches Phase 2 HORIZON Trial of TNX-102 SL for Major Depressive Disorder  The Clinical Trial Vanguard